Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
36
Number of overlapping holdings
10.4%
% of FHLC's 369 holdings also in IHE
97.3%
% of IHE's 38 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in IHE |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 19.2% | 10.2% |
|
JOHNSON & JOHNSON | 6.1% | 22.2% | 6.1% |
|
MERCK & CO. INC. | 5.0% | 4.0% | 4.0% |
|
PFIZER INC | 2.7% | 4.0% | 2.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.6% | 5.5% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to IHE
|
UNITEDHEALTH GROUP INC | 8.3% |
|
ABBVIE INC | 5.2% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% |
|
DANAHER CORP | 3.0% |
|
ABBOTT LABORATORIES | 2.9% |
|
AMGEN INC | 2.8% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
|
ELEVANCE HEALTH INC | 1.9% |
|
REGENERON PHARMACEUTICALS | 1.8% |
FHLC Underweight Relative to IHE
|
JOHNSON & JOHNSON | -16.1% |
|
ELI LILLY & CO | -9.0% |
|
VIATRIS, INC. | -5.1% |
|
CATALENT INC | -4.2% |
|
ROYALTY PHARMA PLC CLASS A | -3.9% |
|
BRISTOL-MYERS SQUIBB CO | -3.9% |
|
INTRA-CELLULAR THERAPIES INC | -3.3% |
|
ZOETIS INC | -3.1% |
 |
JAZZ PHARMACEUTICALS PLC | -3.0% |
|
ELANCO ANIMAL HEALTH, INC. | -2.8% |